MIR449A Gene

HGNC Family Non-coding RNAs
Name microRNA 449a
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMiR‐449a has emerged as a multifunctional regulator in cancer where, in most contexts, it acts as a tumor suppressor. In a number of solid tumors—including prostate, bladder, lung, ovarian, endometrial, glioblastoma, breast, and nasopharyngeal carcinomas—its ectopic expression is associated with induction of cell‐cycle arrest, apoptosis, and senescence. Mechanistically, miR‐449a downregulates key cell‐cycle regulators and oncogenic drivers such as HDAC1, Cyclin D1, CDK6, CDC25A, and BCL2, as well as critical transcription factors including E2F1, MAZ, and CRIP2. In addition, miR‐449a has been shown to enhance the efficacy of ionizing radiation by promoting DNA damage, amplifying G2/M arrest through modulation of the pRb/E2F1 axis and c‐Myc, while in certain breast cancer settings its dysregulated overexpression may contribute to more aggressive behavior. Collectively, these studies highlight miR‐449a as a central mediator of oncogenic signaling and therapeutic responsiveness in a spectrum of malignancies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "27"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its role in tumor suppression, miR‐449a is a conserved regulator of cell differentiation and tissue morphogenesis. In multiciliated epithelia such as those lining the human airway, miR‐449a promotes centriole biogenesis and multiciliogenesis by directly inhibiting the Delta/Notch pathway. It also modulates differentiation processes in other tissues—including the intestinal epithelium and cartilage—by targeting key transcriptional regulators like LEF1, KLF4, and factors involved in chondrogenesis. These findings underscore a critical role for miR‐449a in coordinating complex developmental and regenerative programs."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "28", "end_ref": "34"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in oncogenesis and differentiation, miR‐449a influences inflammatory, metabolic, and viral‐related processes. In the liver, diminished miR‐449a levels have been associated with enhanced hepatitis B virus replication and HCV‐mediated fibrogenesis via modulation of transcription factors such as CREB5, FXRα, and HNF4α that regulate inflammatory chemokine expression. Similarly, altered miR‐449a content in germ cells has been correlated with early life stress and may contribute to the intergenerational transmission of stress phenotypes. Furthermore, miR‐449a has been implicated in regulating osteogenic differentiation relevant to vascular calcification. Together, these studies reveal the multifaceted nature of miR‐449a as a modulator of immune responses, viral replication, and metabolic homeostasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "35", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "E J Noonan, R F Place, D Pookot, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-449a targets HDAC-1 and induces growth arrest in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2009.19"}], "href": "https://doi.org/10.1038/onc.2009.19"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19252524"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19252524"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "M Lizé, S Pilarski, M Dobbelstein "}, {"type": "b", "children": [{"type": "t", "text": "E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cdd.2009.188"}], "href": "https://doi.org/10.1038/cdd.2009.188"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19960022"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19960022"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Emily J Noonan, Robert F Place, Shashwati Basak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.167"}], "href": "https://doi.org/10.18632/oncotarget.167"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20948989"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20948989"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hong Chen, Yi-wei Lin, Ye-qing Mao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2012.01.027"}], "href": "https://doi.org/10.1016/j.canlet.2012.01.027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22266187"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22266187"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Wenting Luo, Bo Huang, Zixuan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0064759"}], "href": "https://doi.org/10.1371/journal.pone.0064759"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23734217"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23734217"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yilong Yao, Jun Ma, Yixue Xue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Oncol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molonc.2014.11.003"}], "href": "https://doi.org/10.1016/j.molonc.2014.11.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25487955"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25487955"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Zhenze Zhao, Xiuye Ma, Derek Sung, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "RNA Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15476286.2015.1023495"}], "href": "https://doi.org/10.1080/15476286.2015.1023495"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25760387"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25760387"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Jie Chen, Jinsong Zhou, Xin Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-3568-y"}], "href": "https://doi.org/10.1007/s13277-015-3568-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26002578"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26002578"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Yanqi Zhou, Qiaoyun Chen, Rong Qin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-014-2551-3"}], "href": "https://doi.org/10.1007/s13277-014-2551-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25179844"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25179844"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Wei Shi, Jeff Bruce, Matthew Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-449a promotes breast cancer progression by targeting CRIP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.7753"}], "href": "https://doi.org/10.18632/oncotarget.7753"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26934316"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26934316"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Bin Xu, Xiping Zhang, Shanshan Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-449a suppresses cell migration and invasion by targeting PLAGL2 in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2017.12.012"}], "href": "https://doi.org/10.1016/j.prp.2017.12.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29653747"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29653747"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Huiling Li, Xiaoling Li, Xiaolu Ge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.10761"}], "href": "https://doi.org/10.18632/oncotarget.10761"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27458165"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27458165"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Ai-Gang Sun, Fan-Guo Meng, Ming-Guang Wang "}, {"type": "b", "children": [{"type": "t", "text": "CISD2 promotes the proliferation of glioma cells via suppressing beclin‑1‑mediated autophagy and is targeted by microRNA‑449a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2017.7642"}], "href": "https://doi.org/10.3892/mmr.2017.7642"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28983596"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28983596"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Yonglei Liu, Yutong Wang, Xiangjun Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-449a promotes liver cancer cell apoptosis by downregulation of Calpain 6 and POU2F1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.4821"}], "href": "https://doi.org/10.18632/oncotarget.4821"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26375440"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26375440"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Jin-Chun Qi, Zhan Yang, Tao Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CDK13 upregulation-induced formation of the positive feedback loop among circCDK13, miR-212-5p/miR-449a and E2F5 contributes to prostate carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-020-01814-5"}], "href": "https://doi.org/10.1186/s13046-020-01814-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33390186"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33390186"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Aihong Mao, Yang Liu, Yali Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-449a enhances radiosensitivity through modulating pRb/E2F1 in prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-4336-8"}], "href": "https://doi.org/10.1007/s13277-015-4336-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26520443"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26520443"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Yi-Jyun Liu, Yu-Fen Lin, Yi-Fan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-449a enhances radiosensitivity in CL1-0 lung adenocarcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0062383"}], "href": "https://doi.org/10.1371/journal.pone.0062383"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23614048"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23614048"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Er-bao Zhang, Rong Kong, Dan-dan Yin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.1902"}], "href": "https://doi.org/10.18632/oncotarget.1902"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24810364"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24810364"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jianghong Hu, Yue Fang, Yuan Cao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dig Dis Sci (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10620-013-2923-3"}], "href": "https://doi.org/10.1007/s10620-013-2923-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24248414"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24248414"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Xihai Wu, Yunhui Han, Fangmei Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Comput Biol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/cmb.2019.0215"}], "href": "https://doi.org/10.1089/cmb.2019.0215"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31513434"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31513434"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Aihong Mao, Qiuyue Zhao, Xin Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-449a enhances radiosensitivity by downregulation of c-Myc in prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep27346"}], "href": "https://doi.org/10.1038/srep27346"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27250340"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27250340"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Shu-Peng Chen, Bao-Xin Liu, Jie Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-015-1738-3"}], "href": "https://doi.org/10.1186/s12885-015-1738-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26471185"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26471185"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "J You, Y Zhang, B Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-449a inhibits cell growth in lung cancer and regulates long noncoding RNA nuclear enriched abundant transcript 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Indian J Cancer (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4103/0019-509X.154055"}], "href": "https://doi.org/10.4103/0019-509X.154055"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25818739"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25818739"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Xiaoping Li, Hong Li, Rui Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-449a inhibits proliferation and induces apoptosis by directly repressing E2F3 in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000374010"}], "href": "https://doi.org/10.1159/000374010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25871967"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25871967"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Maria Sandbothe, Reena Buurman, Nicole Reich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hepatol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jhep.2017.01.004"}], "href": "https://doi.org/10.1016/j.jhep.2017.01.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28088579"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28088579"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Nian Deng, Longyang Li, Jinghao Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hsa_circ_0009910 promotes carcinogenesis by promoting the expression of miR-449a target IL6R in osteosarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2017.11.028"}], "href": "https://doi.org/10.1016/j.bbrc.2017.11.028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29117539"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29117539"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Honglei Wang, Yi Xiao, Li Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-000911/miR-449a pathway in breast carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2018.4265"}], "href": "https://doi.org/10.3892/ijo.2018.4265"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29431182"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29431182"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Brice Marcet, Benoît Chevalier, Guillaume Luxardi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Control of vertebrate multiciliogenesis by miR-449 through direct repression of the Delta/Notch pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb2241"}], "href": "https://doi.org/10.1038/ncb2241"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21602795"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21602795"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Ryota L Matsuoka, Onanong Chivatakarn, Tudor C Badea, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Class 5 transmembrane semaphorins control selective Mammalian retinal lamination and function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuron (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuron.2011.06.009"}], "href": "https://doi.org/10.1016/j.neuron.2011.06.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21835343"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21835343"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Brice Marcet, Benoît Chevalier, Christelle Coraux, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-based silencing of Delta/Notch signaling promotes multiple cilia formation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cc.10.17.17011"}], "href": "https://doi.org/10.4161/cc.10.17.17011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21857154"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21857154"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Marina Capuano, Laura Iaffaldano, Nadia Tinto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-449a overexpression, reduced NOTCH1 signals and scarce goblet cells characterize the small intestine of celiac patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0029094"}], "href": "https://doi.org/10.1371/journal.pone.0029094"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22194996"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22194996"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Seungil Paik, Ho Sun Jung, Seulgi Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-449a regulates the chondrogenesis of human mesenchymal stem cells through direct targeting of lymphoid enhancer-binding factor-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Stem Cells Dev (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/scd.2011.0732"}], "href": "https://doi.org/10.1089/scd.2011.0732"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22769578"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22769578"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Benoît Chevalier, Anna Adamiok, Olivier Mercey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-34/449 control apical actin network formation during multiciliogenesis through small GTPase pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms9386"}], "href": "https://doi.org/10.1038/ncomms9386"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26381333"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26381333"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Olivier Mercey, Alexandra Popa, Amélie Cavard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterizing isomiR variants within the microRNA-34/449 family."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1873-3468.12595"}], "href": "https://doi.org/10.1002/1873-3468.12595"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28192603"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28192603"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Nayan J Sarma, Venkataswarup Tiriveedhi, Vijay Subramanian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0050826"}], "href": "https://doi.org/10.1371/journal.pone.0050826"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23226395"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23226395"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Nayan J Sarma, Venkataswarup Tiriveedhi, Jeffrey S Crippin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.03060-13"}], "href": "https://doi.org/10.1128/JVI.03060-13"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24429361"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24429361"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Xiaoyong Zhang, Hongyan Liu, Zhanglian Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetically regulated miR-449a enhances hepatitis B virus replication by targeting cAMP-responsive element binding protein 5 and modulating hepatocytes phenotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep25389"}], "href": "https://doi.org/10.1038/srep25389"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27138288"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27138288"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Zhongyan Wang, Peter A Burke "}, {"type": "b", "children": [{"type": "t", "text": "The role of microRNAs in hepatocyte nuclear factor-4alpha expression and transactivation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbagrm.2012.12.009"}], "href": "https://doi.org/10.1016/j.bbagrm.2012.12.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23298640"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23298640"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "David A Dickson, Jessica K Paulus, Virginia Mensah, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced levels of miRNAs 449 and 34 in sperm of mice and men exposed to early life stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Psychiatry (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41398-018-0146-2"}], "href": "https://doi.org/10.1038/s41398-018-0146-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29795112"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29795112"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Rongjian Xu, Min Zhao, Yun Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-449c-5p inhibits osteogenic differentiation of human VICs through Smad4-mediated pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-09390-z"}], "href": "https://doi.org/10.1038/s41598-017-09390-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28821833"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28821833"}]}]}]}
Synonyms MIR-449A, HSA-MIR-449, MIRN449, MIRN449A
NCBI Gene ID 554213
API
Download Associations
Predicted Functions View MIR449A's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR449A's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR449A's ARCHS4 Predicted Functions.

Functional Associations

MIR449A has 751 functional associations with biological entities spanning 5 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 17 datasets.

Click the + buttons to view associations for MIR449A from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR449A gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR449A gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR449A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR449A gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
CTD Gene-Disease Associations diseases associated with MIR449A gene/protein from the curated CTD Gene-Disease Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR449A gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR449A gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR449A gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR449A gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR449A from the GeneSigDB Published Gene Signatures dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR449A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR449A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by MIR449A gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR449A gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Reactome Pathways 2014 pathways involving MIR449A protein from the Reactome Pathways dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR449A gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
WikiPathways Pathways 2014 pathways involving MIR449A protein from the Wikipathways Pathways 2014 dataset.